Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Québec, Quebec, Canada
- Facility name not stated
Sherbrooke, Quebec, Canada
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Columbus, Ohio, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Madison, Wisconsin, United States
- Facility name not stated
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 9 May 2014
- Registered enrollment
- 45
- Registry id
- NCT00121420
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.